Clinical trials of varicella vaccine in healthy children

Infectious Disease Clinics of North America

Volumn 10, Issue 3, 1996, Pages 595-608

  White, C J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

CHICKENPOX; CLINICAL TRIAL; DRUG SAFETY; FEVER; HERPES ZOSTER; HUMAN; IMMUNITY; IMMUNOGENICITY; PAIN; RASH; REVIEW; VACCINATION;

EID: 0029794350     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0891-5520(05)70315-9     Document Type: Review

References (74)

1. F.E. Andre Worldwide experience with Oka strain live varicella vaccine Postgrad Med J 61 suppl 4 1985 113 120
2. A.M. Arbeter S. Starr L. Baker Advances with the varicella vaccine Pediatr Res 19 1985 286A
3. A.M. Arbeter S.E. Starr S.A. Plotkin Varicella vaccine studies in healthy children and adults Pediatrics 78 suppl 1986 748 756
4. A.M. Arbeter S.E. Starr S.R. Preblud Varicella vaccine trials in healthy children: A summary of comparative and follow-up studies Am Intern Dis Child 138 1984 434 438
5. A.M. Arbeter S.E. Starr R.E. Weibel Live attenuated varicella vaccine: Immunization of healthy children with the Oka strain J Pediatr 100 1982 886 893
6. A.M. Arvin The T-lymphocyte response to varicella zoster virus and its relevance to vaccine development Reviews in Medical Virology 4 1994 161 175
7. A.M. Arvin C.M. Koropchak B.R.G. Williams Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection J Infect Dis 154 1986 422 429
8. Y. Asano T. Nagai R. Miyata Long-term protective immunity of recipients of the Oka strain of varicella virus vaccine Pediatrics 75 1985 667 671
9. Y. Asano H. Nakayama T. Yazaki Protection against varicella in family contacts by immediate inoculation with live varicella vaccine Pediatrics 59 1977 3 7
10. Y. Asano S. Suga T. Yoshikawa Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine Pediatrics 94 1994 524 526
11. Y. Asano M. Takahashi Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster Biken J 21 1978 15
12. Y. Asano T. Yazaki S. Ito Contract infection from live varicella vaccine recipients Lancet i 1976 965
13. H.F. Balfour J.M. Kelly C.S. Suarez Acyclovir treatment of varicella in otherwise healthy children J Pediatr 116 1990 633 639
14. R. Bergen P. Diaz A.M. Arvin The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content J Infect Dis 162 1990 1049 1054
15. R. Berger G. Florent M. Just Decrease of the lymphoproliferate response to varicella zoster virus antigen in the aged Infect Immun 32 1981 24 27
16. H.H. Bernstein E.P. Rothstein B.M. Watson Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine Pediatrics 92 1993 833 837
17. P. Brunell Brunell's brush off Pediatrics 59 1977 954
18. Chartrand SA, Madison BG, Steinberg AA, et al: Varicella vaccine in day care centers [abstract 454]. In Program and Abstracts of the 23rd International Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, October 1, 1985, p 174
19. P.S. Diaz D. Au S. Smith Lack of transmission of the live attenuated varicella vaccine to immunocompromised children after immunization of their siblings Pediatrics 87 1991 166 170
20. P.S. Diaz S. Smith E. Hunter Immunity to whole varicella-zoster virus antigen and glycoproteins I and PL70: Relation to the immunizing regime of live attenuated varicella vaccine J Infect Dis 158 1988 1245 1252
21. P.S. Diaz S. Smith E. Hunter T-lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine J Immunol 142 1989 636 641
22. L.M. Dunkle A.M. Arvin R.J. Whitley A controlled trial of acyclovir for chicken pox in normal children N Engl J Med 325 1991 1539 1544
23. J.A. Englund C.S. Suarez J. Kelly Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine J Pediatr 114 1989 37 44
24. G. Fleisher W. Henry M. McSorley Life-threatening complications of varicella American Journal of Diseases of Children 135 1981 896 899
25. D. Gelb P.E. Donner A.A. Gershon Molecular epidemiology of live attenuated varicella virus vaccine in children with leukemia and in normal adults J Infect Dis 155 1987 633
26. A.A. Gershon Z.G. Kalter S. Steinberg Detection of antibody to varicella-zoster virus by immune adherence hemagglutination Proc Soc Exp Biol Med 151 1976 762 765
27. R.H. Giller S. Winistorfer C. Grose Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects J Infect Dis 160 1989 919 928
28. H.A. Guess D.D. Broughton L.J. Melton Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981 American Journal of Diseases of Children 138 1984 1055 1057
29. C. Hall P.J. Chesney D. Gromisch Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Pediatrics 95 1995 791 796
30. I.B. Hardy A. Gershon S. Steinberg NIAID collaborative varicella vaccine study group: The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia N Engl J Med 325 1991 1545 1550
31. A.R. Hayward M. Herberger Lymphocyte responses to varicella-zoster virus in the elderly J Clin Immunol 7 1987 174 178
32. R.E. Hope-Simpson The nature of herpes zoster: A long term study and a new hypothesis Proc R Soc Med 58 1965 9 20
33. K. Horiuchi Chickenpox vaccination of healthy children: Immunological and clinical responses and protective effect in 1978-1982 Biken J 27 1984 37 38
34. M.A. Jackson V.F. Burry L.C. Olson Complications of varicella requiring hospitalization in previously healthy children Pediatr Infect Dis J 11 1992 441 445
35. C.E. Johnson L.P. Rome R. Stancin Humoral immunity and clinical reinfections following varicella vaccine in healthy children Pediatrics 84 1989 418 421
36. C.E. Johnson L.P. Rome R. Stancin Live attenuated vaccine in healthy 12 to 24-month-old children Pediatrics 81 1988 512 518
37. M. Just R. Berger V. Just Evaluation of a combined measles-mumps-rubella-chickenpox vaccine Dev Biol Stand 65 1986 85 88
38. H. Kamiya T. Ihara A. Hattori Diagnostic skin rest reactions with varicella virus antigen and clinical application of the test J Infect Dis 136 1977 784 788
39. N. Katsushima N. Yazaki M. Sakamoto Effect and follow-up study on varicella vaccine Biken J 27 1984 51 58
40. H. Kempe A. Gershon Varicella vaccine at the crossroads Pediatrics 60 1978 930 931
41. D.L. Krah P.J. Provost R.W. Ellis Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella zoster virus J Virol Methods 53 1995 176 187
42. B.J. Kuter R.E. Weibel H.A. Guess Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies Vaccine 9 1991 643 647
43. P. LaRussa O. Lungu I. Hardy Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster isolates J Virol 66 1992 1016 1026
44. E. Somekh M. Levin Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine J Med Virol 40 1993 241 243
45. T.A. Lieu S.L. Vochi S.B. Black Cost effectiveness of a routine varicella vaccination program for US children JAMA 271 1994 375 381
46. A.E. Miller Selective decline in cellular immune response to varicella zoster in the elderly Neurology 30 1980 582 587
47. Y. Naganuma S. Osawa R. Takahashi Clinical application of a live varicella vaccine (Oka strain) in a hospital Biken J 27 1984 59 61
48. H. Naruse H. Miwata T. Ozaki Varicella infection complicated with meningitis after immunization: Case report Acta Paediatr Jpn 35 1993 345 347
49. B. Neff R. Weibel V.M. Villarejos Clinical and laboratory studies of KMcC strain live attenuated varicella virus (41071) Proc Soc Exp Biol Med 166 1981 339 347
50. T. Osaki T. Matsui R. Ichikawa Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children Biken J 27 1984 39 42
51. P.A. Patel S. Yoonessi J. O'Malley Cell-mediated immunity to varicella zoster virus infection in subjects with lymphoma or leukemia J Pediatr 94 1979 223 230
52. S.A. Plotkin Varicella vendetta: Plotkin's plug Pediatrics 59 1977 954
53. S.A. Plotkin S.E. Starr K. Conner D. Morton Zoster in normal children after varicella vaccine J Infect Dis 159 5 1988 1000 1001
54. S.R. Preblud Age-specific risks of varicella complication Pediatrics 68 1981 14 17
55. S.R. Preblud W.A. Orenstein J.P. Koplan A benefit-cost analysis of a childhood varicella vaccination programme Postgrad Med 61 1985 17 22
56. P.J. Provost D.L. Krah B.J. Kuter Antibody assay suitable for assessing immune responses to live varicella vaccine Vaccine 9 1991 111 116
57. M.W. Ragozzino L.J. Melton L.T. Kurland Population-based study of herpes zoster and its sequelae Medicine 61 1982 310 316
58. A.H. Ross E. Lecher G. Reitman Modification of chickenpox in family contacts by administration of gamma globulin N Engl J Med 267 1962 369 376
59. N.J. Schmidt E.H. Lennette Neutralizing antibody responses to varicella-zoster virus Infect Immun 12 1975 606 613
60. Z. Shehab P. Brunell Enzyme-linked immunosorbent assay for susceptibility to varicella J Infect Dis 148 1983 472 476
61. M. Takahashi Development and characterization of a live varicella vaccine (Oka strain) Biken J 27 1984 31 36
62. M. Takahashi Y. Okuno T. Otuka Development of a live attenuated varicella vaccine Biken J 18 1975 25 33
63. M. Takahashi T. Otsuka Y. Okuno Live vaccine used to prevent the spread of varicella in children in hospital Lancet 2 1974 1288 1290
64. M. Tsolia A. Gershon S. Steinberg Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus J Pediatr 116 1990 184 189
65. Varis T, Vesikari T, Scrumnen T, et al: Safety, immunogenicity and efficacy of high vs. low dose varicella vaccine in healthy children [abstract 1541]. In Program and Abstracts of the 33rd International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 1993, p 401
66. E.H. Wasmuth W.J. Miller A sensitive enzyme-linked immunosorbent assay (ELISA) for antibody to varicella-zoster virus using purified VZV glycoprotein antigens J Med Virol 32 1990 189 193
67. B. Watson R. Gupta T. Randall Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine J Infect Dis 169 1994 197 199
68. B. Watson P.M. Keller R.W. Ellis Cell-mediated immune response after immunization of healthy seronegative children with varicella vaccine: Kinetics and specificity J Infect Dis 162 1990 794 799
69. B. Watson S.A. Piercy S.A. Plotkin Modified chickenpox in children immunized with the Oka/Merck varicella vaccine Pediatrics 91 1993 17 22
70. R.E. Weibel B.J. Kuter B.J. Neff Live Oka/Merck varicella vaccine in healthy children JAMA 254 1985 2435 2439
71. Wharton M, Fehrs LJ, Cochi SL, et al: Health impact of varicella in the 1980s [abstract 1136]. In Programs and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, September 1990, p 276
72. C.J. White B.J. Kuter C.S. Hildebrand Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from 1987-1989 clinical trials Pediatrics 87 1991 604 610
73. C.J. White B.J. Kuter A. Ngai Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response Pediatr Infect Dis J 11 1992 19 23
74. V. Williams A. Gershon P. Brunell Serologic responses to varicella zoster membrane antigens measured by indirect immunofluorescence J Infect Dis 130 1974 669